v3.26.1
10-K Redeemable non-controlling interest - Narrative (Details)
$ in Thousands, € in Millions
1 Months Ended
Apr. 30, 2026
EUR (€)
installment
Jul. 02, 2025
USD ($)
shares
Apr. 07, 2021
USD ($)
Sep. 30, 2022
Mar. 31, 2026
USD ($)
Feb. 23, 2026
Dec. 31, 2025
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Redeemable Noncontrolling Interest [Line Items]                      
Redeemable non-controlling interest contingency   $ 102,100     $ 87,997   $ 83,931 $ 149,079 $ 132,179 $ 120,650 $ 121,113
Put/call option trigger period       2 years              
Subsequent events                      
Redeemable Noncontrolling Interest [Line Items]                      
Put option settlement, consideration transferred | € € 76.5                    
Put option settlement, consideration transferred, cash | € 43.0                    
Put option settlement, consideration transferred, deferred | € 12.2                    
Put option settlement, consideration transferred, equity | € € 21.3                    
Put option settlement, consideration transferred, deferred, number of installment | installment 2                    
Put option settlement, consideration transferred, deferred, interest rate 6.00%                    
SVS                      
Redeemable Noncontrolling Interest [Line Items]                      
Issuance of SVS to settle non-controlling interest (in shares) | shares   2,270,284                  
Curaleaf International Holdings Limited                      
Redeemable Noncontrolling Interest [Line Items]                      
Percentage of ownership   100.00%         100.00%   68.50%    
Redeemable non-controlling interest contingency             $ 0   $ 94,561 105,087  
Redeemable non-controlling interest, redemption value   $ 5,400                  
Four20 Pharma GmbH                      
Redeemable Noncontrolling Interest [Line Items]                      
Ownership interest by minority shareholders           45.00% 45.00%   45.00%    
Percentage of ownership             55.00%   55.00%    
Redeemable non-controlling interest contingency             $ 83,931   $ 37,618 $ 15,563  
Four20 Pharma GmbH | Subsequent events                      
Redeemable Noncontrolling Interest [Line Items]                      
Ownership interest by minority shareholders           45.00%          
Strategic investor | Curaleaf International Holdings Limited                      
Redeemable Noncontrolling Interest [Line Items]                      
Proceeds from minority interest investment     $ 130,800                
Ownership interest by minority shareholders     31.50%